Claude Knopf – Biography
Last update: April 15, 2026Executive profile
Claude was Chief Business Officer at Gemini Therapeutics, and Chief Business Officer at Pieris Pharmaceuticals.
Claude Knopf is currentlyChief Business Officer at ImCheck Therapeutics - View - ImCheck Therapeutics org chart
Create your alert
to follow the career of Claude Knopf.
Education
Claude Knopf has a Post-Graduate Course, Clinical Development from Tufts University and an Executive Education, Mergers and Acquisitions from University of Pennsylvania - The Wharton School.
They have also studied at Tufts University :
Find more alumni from Tufts University
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
More about Claude Knopf
Selected links
Do you need to know more about Claude Knopf? More results.
Participate
Social media
- Claude Knopf on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Claude Knopf
The colleagues of Claude Knopf
Company Colleagues
- At ImCheck Therapeutics, Claude Knopf has 11 colleagues including Pierre d'Epenoux (CEO & Director), Sophie Agaugue (Preclinical Research)…
Industry Colleagues
- In the Biotechnology industry, Claude Knopf has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Claude Knopf.
Get in Touch
Here are a few tips for establishing great contacts.
